These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8869831)

  • 1. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock.
    Glauser MP
    Drugs; 1996; 52 Suppl 2():9-17. PubMed ID: 8869831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.
    Dinarello CA
    J Infect Dis; 1991 Jun; 163(6):1177-84. PubMed ID: 2037782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of cytokines in endotoxic shock and in endotoxin hypersensitivity].
    Freudenberg MA; Ness T; Kumazawa Y; Galanos C
    Immun Infekt; 1993 Apr; 21(2):40-4. PubMed ID: 8340136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines and antagonists in septic shock].
    Girardin E; Dayer JM
    Schweiz Med Wochenschr; 1993 Mar; 123(11):480-91. PubMed ID: 8386392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cachectin or TNF (tumor necrosis factor): clinical implications].
    Romieu M; Riche F; Bousseau A; Szekeli B; Schurando P; Briard C; Payen D
    Ann Fr Anesth Reanim; 1990; 9(6):525-35. PubMed ID: 2278419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moesin: a potential LPS receptor on human monocytes.
    Amar S; Oyaisu K; Li L; Van Dyke T
    J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice from LPS-induced shock by CD14 antisense oligonucleotide.
    Furusako S; Takahashi T; Mori S; Takahashi Y; Tsuda T; Namba M; Mochizuki H
    Acta Med Okayama; 2001 Apr; 55(2):105-15. PubMed ID: 11332197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E
    An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
    [No Abstract]   [Full Text] [Related]  

  • 12. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.
    Taylor FB; Chang A; Ruf W; Morrissey JH; Hinshaw L; Catlett R; Blick K; Edgington TS
    Circ Shock; 1991 Mar; 33(3):127-34. PubMed ID: 2044206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against CD14 protect primates from endotoxin-induced shock.
    Leturcq DJ; Moriarty AM; Talbott G; Winn RK; Martin TR; Ulevitch RJ
    J Clin Invest; 1996 Oct; 98(7):1533-8. PubMed ID: 8833900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Septic shock in newborn infants].
    Mancilla-Ramírez J
    Bol Med Hosp Infant Mex; 1992 Nov; 49(11):766-76. PubMed ID: 1466777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of bacterial endotoxins, receptors and cytokines in the pathogenesis of septic (endotoxin) shock].
    Lazarov S; Balutsov M; Ianev E
    Vutr Boles; 2000; 32(4):33-40. PubMed ID: 11688328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen and endotoxin synergize in the induction of lethal shock.
    Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
    Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in the adjunct therapy of severe sepsis.
    Verhoef J; Hustinx WM; Frasa H; Hoepelman AI
    J Antimicrob Chemother; 1996 Aug; 38(2):167-82. PubMed ID: 8877531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
    Van Amersfoort ES; Van Berkel TJ; Kuiper J
    Clin Microbiol Rev; 2003 Jul; 16(3):379-414. PubMed ID: 12857774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoglobulins in sepsis and septic shock].
    Salinas J; Fica A
    Rev Chilena Infectol; 2005 Mar; 22(1):21-31. PubMed ID: 15798866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.